890
·
01-12
Bank Stocks Start 2026 Strong Why bank stocks have been leading again Banks are basically a "macro bundle" in one ticker: growth, rates, credit, and market activity. What has gone right recently is the combo platter: Rates stayed high enough for long enough to keep net interest income resilient, even as investors began to price in eventual cuts. That "not too hot, not too cold" rate path matters more to banks than the absolute level. Credit has not cracked in a way that forces a big spike in provisions, so earnings have looked "boringly dependable," which the market tends to reward when the tape gets crowded in more fragile narratives. Capital markets woke up: underwriting calendars and deal chatter have improved, and early 2026 issuance activity has been busy, which tends to flow through
TOPtothehill: Macro resilience is key for banks lah! Fee engines firing up nicely.[看涨]
812
·
01-12
Tesla Quick Take: 2026 Could See Unsupervised Robotaxi and FSD Launch Robotaxi and FSD largely support $Tesla Motors(TSLA)$
TOPTesla's Robotaxi rollout looks promising! Bullish on $TSLA.[看涨]
1.34K
·
01-12
[Tiger Poll] Which Big Bank Is Your Best Bet This Earnings Season?
Wall Street earnings season is kicking off—and the Big 6 U.S. banks are once again leading the charge.JPMorgan, Citigroup, Bank of America, Wells Fargo, Goldman Sachs, and Morgan Stanley are all set to report their Q4 results this week. Analysts are generally bullish, expecting strong earnings growth driven by trading rebounds, investment banking recovery, and better capital return trends.📆 Earnings ScheduleJan 13 (Mon): $JPMorgan Chase(JPM)$ Jan 14 (Tue): $Citigroup(C)$ , $Bank of America(BAC)$ , $Wells Fargo(WFC)$ Jan 15 (Wed): $Goldman Sachs(GS)$ ,
TOP🌟🌟🌟I vote $Citigroup(C)$ as it is undervalued compared to the other 5 big banks. Citi currently has the lowest forward P/E ratio of 11.9x among the 6 largest US banks. Analysts view Citi as a value and recovery story with potential upside if its restructuring efforts succeed. Surprisingly Citi was the best performing major bank of 2025, rallying 66%. For dividend investors, Citi has a nice juicy dividend yield of 2.04%. @Tiger_comments @TigerStars @TigerClub @CaptainTiger
2.92K
·
01-12
Buying Oil Like a Lottery Ticket—And Why It Might Pay Off
Scarcely had the Venezuela episode quietened than America began casting around for ways to rattle Iran—a sign that Donald Trump is unlikely to lie low before the 2026 midterms. With voters demanding lower inflation and reliable energy supplies, he must be seen to deliver on those pledges. For Mr Trump, the midterms matter more than most.With both chambers of Congress in Republican hands, Mr Trump’s legislative agenda can glide through with little more than a nod from Capitol Hill. But if the midterms strip his party of either the Senate or the House, his second term will soon resemble his first: gridlocked, frustrated, and reduced to bargaining endlessly with Democrats just to get anything done—a president in name only.The consequences of striking Iran?If America follows through, markets w
719
·
01-09
$GDS Holdings Ltd(GDS)$ has been performing solidly — data centers are one of the clearest beneficiaries of the growing AI adoption trend, especially with China’s push on AI infrastructure. The company’s earnings and bookings are strengthening, and the stock’s run feels great!
1.43K
·
01-09
$BitMine Immersion Technologies Inc.(BMNR)$ just crushed it! Caught the crypto concept stock surge and rode it well—especially with the company’s huge ETH holdings and its move into staking and validator networks. The stock’s performance beat expectations and the gains feel awesome! High risk, high reward—feels like I timed it right!
1.21K
·
01-12
$GDS Holdings Ltd(GDS)$ Caught a nice move this round and booked some gains — feels good when the logic and trend line up!
1.09K
·
01-12
$Direxion Daily TSLA Bull 2X Shares(TSLL)$ has been exciting lately — leveraged moves hit hard and fast
521
·
01-12
$Direxion Daily Semiconductors Bull 3x Shares(SOXL)$ is on fire! 9.73% surge on Jan 6 plus 8.66% gain on Jan 9, 29.46% jump in two weeks, 3x leverage amplifies semiconductor boom – massive profits!
950
·
01-12
$Intel(INTC)$ is gaining strong momentum, with government support! $SMIC(00981)$ has already partnered with collaborators and is waiting to be tapped
1.35K
·
01-12
$SoundHound AI Inc(SOUN)$ So glad I held SOUN! "Moderate Buy" consensus with $16.07 avg target (36% upside), 67.6% YoY Q3 revenue beat – strong liquidity fuels gains~
1.55K
·
01-12
$CRITICAL METALS CORPORATION(CRML)$ This stock has now become one of my most anticipated picks. Playing with this kind of high-risk, lottery-like stock is just thrilling.
848
·
01-12
$NuScale Power(SMR)$ Its edge is clear: modular reactors, standardized manufacturing in factories, then shipped and assembled
458
·
01-12
$iShares Silver Trust(SLV)$ moved steadily and strong — solid gains locked in.
1.02K
·
01-12
$ProShares Ultra Silver(AGQ)$ I’ve allocated quite a bit into silver futures and plan to hold for two years to see how much it can make. I’ve already made a decent profit over the past couple of weeks.
728
·
01-12
$SanDisk Corp.(SNDK)$ According to a client report released by Nomura Securities, SanDisk plans to raise prices for its high-capacity 3D NAND flash memory chips used in enterprise-grade solid-state drives (SSD) by more than 100% month over month in March.
2.03K
·
01-12
👇🤔Eli Lilly（LLY） Leads Top 20 Insider Sells Last Week
Hi Tigers~The following are the top 20 stocks with the most Insider Sells in the past week.Data source: Bloomberg, data cutoff date: Jan 9th, 2026.Insider selling stocks does not necessarily mean that there is a problem with the company, but large-scale selling may need to be paid attention to.Firstly, the top 10 insider stock sales, ranked by amount, were $Eli Lilly(LLY)$ , $Rocket Lab USA, Inc.(RKLB)$ , $TransDigm(TDG)$ , $Chevron(CVX)$ , $Legence Corp.(LGN)$ , $Affirm Holdings, Inc.(AFRM)$ , $Oklo I
1.47K
·
01-12
Option Movers | Intel's Volume Surges 2.5 Times; Apple Shows Bearish Sentiment
Market OverviewThe S&P 500 rallied to a record high close on Friday (Jan 9), lifted by Broadcom and other chipmakers, while a weaker-than-expected jobs report did little to alter expectations of interest rate cuts from the Federal Reserve this year.Regarding the options market, a total volume of 59,439,508 contracts was traded.Top 10 Option VolumesTop 10: $TSLA(TSLA)$, $NVDA(NVDA)$, $INTC(INTC)$, $AAPL(AAPL)$, $MSTR(MSTR)$, $NFLX(NFLX)$, $OPEN(OPEN)$,
1.34K
·
01-08
U.S. Healthcare ETFs Lead Defensive Sectors — How Should Healthcare Assets Be Allocated?
In last night’s U.S. equity session, healthcare and pharmaceutical stocks posted broad-based strength, with related healthcare ETFs clearly outperforming the broader market. Against a backdrop of tech sector dispersion and more cautious market sentiment, healthcare has once again moved into focus for capital allocation. From both a fundamental and trading-logic perspective, the rebound in the healthcare sector is not accidental： The defensive profile is reasserting itself: Amid ongoing macro uncertainty, healthcare remains a classic non-cyclical, demand-inelastic sector. With stable cash flows and relatively low earnings volatility, healthcare assets tend to attract inflows when risk appetite moderates. Valuation repair has become a key driver: After the prior correction, overall valuation
1.15K
·
01-09
U.S. Healthcare ETFs Lead in Near-Term Adjustments: Structural Insights Under the Sector’s Defensive Profile
Against a backdrop of heightened market volatility, the U.S. healthcare sector has maintained relatively resilient performance. Compared with the previous trading session, a pullback in overall risk appetite has led to a clearer internal differentiation among healthcare-related ETFs. Volatility remains more pronounced in biotechnology-focused products, while ETFs centered on large-cap pharmaceuticals and diversified healthcare have exhibited comparatively stable performance. Overall, the defensive characteristics of the healthcare sector continue to provide a degree of support under the current market environment. From an internal structural perspective, biotechnology-related ETFs have experienced relatively larger drawdowns, whereas products concentrated in large pharmaceutical companies
TOPPharma ETFs are solid holds amid volatility.[看涨]